Previous close | 46.70 |
Open | 0.00 |
Bid | 48.15 x 0 |
Ask | 48.55 x 0 |
Day's range | 0.00 - 0.00 |
52-week range | |
Volume | |
Avg. volume | 189 |
Market cap | 1.013T |
Beta (5Y monthly) | 0.74 |
PE ratio (TTM) | 32.90 |
EPS (TTM) | N/A |
Earnings date | N/A |
Forward dividend & yield | 0.69 (1.47%) |
Ex-dividend date | 12 Jul 2024 |
1y target est | N/A |
We recently compiled a list of the 10 Best Dividend Kings to Buy for Safe Dividend Growth. In this article, we are going to take a look at where Abbott Laboratories (NYSE:ABT) stands against the other dividend stocks. Investors often closely track the fluctuations of the stock market, eagerly expecting price increases. However, they may overlook […]
Weight-loss breakthroughs all emerged from diabetes treatment. Meetings such as the coming American Diabetes Association are increasingly dominated by news on obesity drugs.
Abbott (ABT) concluded the recent trading session at $103.45, signifying a -0.22% move from its prior day's close.